These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8650062)

  • 21. Low-dose tacrolimus for two cases of myasthenia gravis with invasive thymoma that relapsed shortly after thymectomy.
    Tsukaguchi M; Shimamura M; Ikeda K; Urai Y; Sasaki I; Deguchi K; Touge T; Takeuchi H; Kuriyama S
    J Neurol Sci; 2005 Apr; 231(1-2):85-8. PubMed ID: 15792826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-dose intravenous immunoglobulin for the treatment of MuSK antibody-positive seronegative myasthenia gravis.
    Takahashi H; Kawaguchi N; Nemoto Y; Hattori T
    J Neurol Sci; 2006 Sep; 247(2):239-41. PubMed ID: 16876198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasmapheresis or intravenous immunoglobulin for myasthenia gravis crisis in King Chulalongkorn Memorial Hospital.
    Pittayanon R; Treeprasertsuk S; Phanthumchinda K
    J Med Assoc Thai; 2009 Apr; 92(4):478-82. PubMed ID: 19374297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Contribution of intravenous immunoglobulins to the treatment of myasthenia].
    Gajdos P
    Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S30-4. PubMed ID: 10896986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. International consensus guidance for management of myasthenia gravis: Executive summary.
    Sanders DB; Wolfe GI; Benatar M; Evoli A; Gilhus NE; Illa I; Kuntz N; Massey JM; Melms A; Murai H; Nicolle M; Palace J; Richman DP; Verschuuren J; Narayanaswami P
    Neurology; 2016 Jul; 87(4):419-25. PubMed ID: 27358333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma exchange versus intravenous immunoglobulin treatment in myasthenic crisis.
    Qureshi AI; Choudhry MA; Akbar MS; Mohammad Y; Chua HC; Yahia AM; Ulatowski JA; Krendel DA; Leshner RT
    Neurology; 1999 Feb; 52(3):629-32. PubMed ID: 10025801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Intensive care in myasthenic and cholinergic crises].
    Popova LM; Piradov MA
    Anesteziol Reanimatol; 1996; (2):13-5. PubMed ID: 8754165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-musk antibody after thymectomy in a previously seropositive myasthenic child.
    Saulat B; Maertens P; Hamilton WJ; Bassam BA
    Neurology; 2007 Aug; 69(8):803-4. PubMed ID: 17709714
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Myasthenia Gravis Clinical Study Group.
    Gajdos P; Chevret S; Clair B; Tranchant C; Chastang C
    Ann Neurol; 1997 Jun; 41(6):789-96. PubMed ID: 9189040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aseptic meningitis as a complication of intravenous immunoglobulin therapy for myasthenia gravis.
    Ellis RJ; Swendson MR; Bajorek J
    Muscle Nerve; 1994 Jun; 17(6):683-4. PubMed ID: 8196714
    [No Abstract]   [Full Text] [Related]  

  • 31. Myasthenic crisis following iodinated contrast material (iohexol) aspiration: a case report.
    Bopeththa BVKM; Hewavithana PB; Hewapathirana HLI; Ralapanawa U
    J Med Case Rep; 2019 May; 13(1):166. PubMed ID: 31146780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A diagnostic and management dilemma: combined paraneoplastic myasthenia gravis and Lambert-Eaton myasthenic syndrome presenting as acute respiratory failure.
    Roohi F; Smith PR; Bergman M; Baig MA; Sclar G
    Neurologist; 2006 Nov; 12(6):322-6. PubMed ID: 17122730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How the application of human immunoglobulin in the treatment of myasthenia crisis changed the outcome of the disease.
    Suljic E; Kavazovic A; Loncarevic N
    Med Arh; 2010; 64(1):7-10. PubMed ID: 20422815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of the effectiveness of intravenous immunoglobulin and plasma exchange as preoperative therapy of myasthenia gravis.
    Jensen P; Bril V
    J Clin Neuromuscul Dis; 2008 Mar; 9(3):352-5. PubMed ID: 18344718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Myasthenia and pregnancy].
    Stoĭkov S; Popov I
    Akush Ginekol (Sofiia); 1999; 38(4):48-51. PubMed ID: 10726355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Plasmapheresis and immunoglobulin therapy].
    Matsuo H
    Rinsho Shinkeigaku; 2012; 52(11):1051-2. PubMed ID: 23196512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapy in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
    Newsom-Davis J
    Semin Neurol; 2003 Jun; 23(2):191-8. PubMed ID: 12894384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Association of plasmapheresis and high doses of intravenous immunoglobulins in the treatment of myasthenia gravis].
    Tatay J; Díez-Tejedor E; Frank A; Tejada J; Marrero C; Barreiro P
    Rev Neurol; 1997 Sep; 25(145):1402-6. PubMed ID: 9377299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous immunoglobulin as treatment for myasthenia gravis: current evidence and outcomes.
    Alabdali M; Barnett C; Katzberg H; Breiner A; Bril V
    Expert Rev Clin Immunol; 2014 Dec; 10(12):1659-65. PubMed ID: 25331319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myasthenia gravis and myasthenic syndrome.
    Antozzi C
    Neurol Sci; 2003 Oct; 24 Suppl 4():S260-3. PubMed ID: 14598056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.